Aripiprazole once-monthly 400 mg for long-term maintenance treatment of schizophrenia: a 52-week open-label study.

about

Aripiprazole once-monthly 400 mg for long-term maintenance treatment of schizophrenia: a 52-week open-label study.

Item

http://www.wikidata.org/entity/Q40765718

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Aripiprazole once-monthly 400 ...... a: a 52-week open-label study.

@en

type

Item

label

Aripiprazole once-monthly 400 ...... a: a 52-week open-label study.

@en

prefLabel

Aripiprazole once-monthly 400 ...... a: a 52-week open-label study.

@en

P1476

Aripiprazole once-monthly 400 ...... a: a 52-week open-label study.

@en

P2093

Anna Duca

http://www.w3.org/2001/XMLSchema#string

Anna Eramo

http://www.w3.org/2001/XMLSchema#string

Brian R Johnson

http://www.w3.org/2001/XMLSchema#string

Na Jin

http://www.w3.org/2001/XMLSchema#string

Pamela Perry

http://www.w3.org/2001/XMLSchema#string

Raymond Sanchez

http://www.w3.org/2001/XMLSchema#string

Robert D McQuade

http://www.w3.org/2001/XMLSchema#string

Ross A Baker

http://www.w3.org/2001/XMLSchema#string

Timothy Peters-Strickland

http://www.w3.org/2001/XMLSchema#string

P2860

Impact of long-acting injectable antipsychotics on medication adherence and clinical, functional, and economic outcomes of schizophrenia

Hospitalization and psychosis: influences on the course of cognition and everyday functioning in people with schizophrenia

A rating scale for drug-induced akathisia

Oral versus depot antipsychotic drugs for schizophrenia--a critical systematic review and meta-analysis of randomised long-term trials.

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects.

Long-term tolerability of once-monthly injectable paliperidone palmitate in subjects with recently diagnosed schizophrenia.

Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants.

Schizophrenia, "just the facts" 5. Treatment and prevention. Past, present, and future.

Aripiprazole intramuscular depot as maintenance treatment in patients with schizophrenia: a 52-week, multicenter, randomized, double-blind, placebo-controlled study.

Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors.

P2888

npjschz.2015.39

P304

15039

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NPJSCHZ.2015.39

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27336044

http://www.w3.org/2001/XMLSchema#string

P921

schizophrenia

P932

4849461

http://www.w3.org/2001/XMLSchema#string